The tetraspanin CD9 controls migration and proliferation of parietal epithelial cells and glomerular disease progression

Archive ouverte

Lazareth, Hélène | Henique, Carole | Lenoir, Olivia | Puelles, Victor | Flamant, Martin | Bollée, Guillaume | Fligny, Cécile | Camus, Marine | Guyonnet, Léa | Millien, Corinne | Gaillard, François | Chipont, Anna | Robin, Blaise | Fabrega, Sylvie | Dhaun, Neeraj | Camerer, Eric | Kretz, Oliver | Grahammer, Florian, F. | Braun, Fabian | Huber, Tobias | Nochy, Dominique | Mandet, Chantal | Bruneval, Patrick | Mesnard, Laurent | Thervet, Eric | Karras, Alexandre | Le Naour, François | Rubinstein, Eric | Boucheix, Claude | Alexandrou, Antigoni | Moeller, Marcus | Bouzigues, Cedric | Tharaux, Pierre-Louis

Edité par CCSD ; Nature Publishing Group -

These authors contributed equally : Hélène Lazareth, Carole Henique, Olivia Lenoir, Victor G. Puelles.These authors jointly supervised this work : François Le Naour, Eric Rubinstein, Claude Boucheix, Antigoni Alexandrou, Marcus J. Moeller.. International audience. The mechanisms driving the development of extracapillary lesions in focal segmental glomerulosclerosis (FSGS) and crescentic glomerulonephritis (CGN) remain poorly understood. A key question is how parietal epithelial cells (PECs) invade glomerular capillaries, thereby promoting injury and kidney failure. Here we show that expression of the tetraspanin CD9 increases markedly in PECs in mouse models of CGN and FSGS, and in kidneys from individuals diagnosed with these diseases. Cd9 gene targeting in PECs prevents glomerular damage in CGN and FSGS mouse models. Mechanistically, CD9 deficiency prevents the oriented migration of PECs into the glomerular tuft and their acquisition of CD44 and β1 integrin expression. These findings highlight a critical role for de novo expression of CD9 as a common pathogenic switch driving the PEC phenotype in CGN and FSGS, while offering a potential therapeutic avenue to treat these conditions.

Suggestions

Du même auteur

Genetic and pharmacological inhibition of microRNA-92a maintains podocyte cell cycle quiescence and limits crescentic glomerulonephritis

Archive ouverte | Henique, Carole | CCSD

International audience. Crescentic rapidly progressive glomerulonephritis (RPGN) represents the most aggressive form of acquired glomerular disease. While most therapeutic approaches involve potentially toxic immuno...

Nuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor γ Essential for Resistance to Crescentic GN

Archive ouverte | Henique, Carole | CCSD

International audience. Necrotizing and crescentic rapidly progressive GN (RPGN) is a life-threatening syndrome characterized by a rapid loss of renal function. Evidence suggests that podocyte expression of the tran...

Nuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor γ Essential for Resistance to Crescentic GN

Archive ouverte | Henique, Carole | CCSD

International audience

Chargement des enrichissements...